Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area
- 17 January 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 192 (3) , 389-395
- https://doi.org/10.1016/0014-2999(91)90230-n
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized ratsEuropean Journal of Pharmacology, 1990
- Hemodynamic and renin responses to (±)-DOI, a selective 5-HT2 receptor agonist, in conscious ratsEuropean Journal of Pharmacology, 1990
- Quipazine Increases Renin Release by a Peripheral Hemodynamic MechanismJournal of Cardiovascular Pharmacology, 1990
- Characterization of DOI, a putative 5-HT2 receptor agonist in the ratEuropean Journal of Pharmacology, 1989
- Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised catsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- 5-HT2 receptor agonists increase spontaneous sympathetic nerve dischargeEuropean Journal of Pharmacology, 1988
- Hypotensive Effect of Urapidil: CNS Site and Relative ContributionJournal of Cardiovascular Pharmacology, 1987
- Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67European Journal of Pharmacology, 1986
- The effects of ketanserin, methysergide and LY 53857 on sympathetic nerve activityEuropean Journal of Pharmacology, 1985
- Reduction in blood pressure, sympathetic nerve discharge and centrally evoked pressor responses by methysergide in anesthetized catsEuropean Journal of Pharmacology, 1977